Type I IFN-β gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis

被引:21
作者
Bartlett, EJ [1 ]
Lenzo, JC [1 ]
Sivamoorthy, S [1 ]
Mansfield, JP [1 ]
Cull, VS [1 ]
James, CM [1 ]
机构
[1] Murdoch Univ, Div Hlth Sci, Western Australian Biomed Res Inst, Murdoch, WA 6150, Australia
关键词
cytomegalovirus; immunotherapy; inflammation; interferon-beta; myocarditis;
D O I
10.1046/j.0818-9641.2004.01234.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Gene therapy using DNA encoding type I IFN subtypes IFNA6, IFNA9 and IFNB suppresses murine cytomegalovirus (MCMV)-myocarditis, a predominantly cell-mediated disease in BALB/c mice. CD8(+) T cells are the principal cell type within the inflamed myocardium. As such, we investigated the effects of IFN subtype treatment on this T-cell subset and other cell types in the cardiac infiltrate. In the acute phase of disease, IFNA6 and IFNA9 treatments significantly reduced the number of CD8(+) T cells within the foci of cellular infiltration in the heart. During the chronic phase, which is primarily autoimmune in nature, IFNB treatment significantly reduced CD8(+) T cells. B-cell and neutrophil numbers in the cardiac infiltrate were also reduced following IFNB immunotherapy. Although early inflammatory responses are important for resolution of virus infection, high numbers of lymphocytes persisting in the myocardium may lead to exacerbation of disease. Our data suggests that type I IFN DNA therapy regulates cardiac cellular infiltration. Thus, treatment with IFN-beta administered prophylactically to high-risk patients in acquiring CMV infection may reduce the development of chronic autoimmune myocarditis.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 52 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]   Infection of dendritic cells by murine cytomegalovirus induces functional paralysis [J].
Andrews, DM ;
Andoniou, CE ;
Granucci, F ;
Ricciardi-Castagnoli, P ;
Degli-Esposti, MA .
NATURE IMMUNOLOGY, 2001, 2 (11) :1077-1084
[3]   Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection [J].
Bartlett, EJ ;
Cull, VS ;
Brekalo, NL ;
Lenzo, JC ;
James, CM .
IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (05) :425-435
[4]  
Biron CA, 1999, CURR OPIN MICROBIOL, V2, P374
[5]   Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells [J].
Bossi, G ;
Griffiths, GM .
NATURE MEDICINE, 1999, 5 (01) :90-96
[6]   The neutrophil: Function and regulation in innate and humoral immunity [J].
Burg, ND ;
Pillinger, MH .
CLINICAL IMMUNOLOGY, 2001, 99 (01) :7-17
[7]   CD8(+) AND CD45RA(+) HUMAN PERIPHERAL-BLOOD LYMPHOCYTES ARE POTENT SOURCES OF MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA, INTERLEUKIN-8 AND RANTES [J].
CONLON, K ;
LLOYD, A ;
CHATTOPADHYAY, U ;
LUKACS, N ;
KUNKEL, S ;
SCHALL, T ;
TAUB, D ;
MORIMOTO, C ;
OSBORNE, J ;
OPPENHEIM, J ;
YOUNG, H ;
KELVIN, D ;
ORTALDO, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (03) :751-756
[8]   Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration [J].
Craigen, JL ;
Yong, KL ;
Jordan, NJ ;
Maccormac, LP ;
Westwick, J ;
Akbar, AN ;
Grundy, JE .
IMMUNOLOGY, 1997, 92 (01) :138-145
[9]   Type I interferon differential therapy for erythroleukemia: specificity of STAT activation [J].
Cull, VS ;
Tilbrook, PA ;
Bartlett, EJ ;
Brekalo, NL ;
James, CM .
BLOOD, 2003, 101 (07) :2727-2735
[10]   Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis [J].
Cull, VS ;
Bartlett, EJ ;
James, CM .
IMMUNOLOGY, 2002, 106 (03) :428-437